2021 International Congress of Diabetes and Metabolism

S3 Epidemiology and genetics 1 : COVID-19 pandemic and management of diabetes in Asia LIVE Channel C	16:30~18:30 / Thursday 7 October Chairman:Hyun Shik Son, Kang Seo Park	Overview
The COVID-19 pandemic is currently the most important global issue facing healthcare systems, and it is expected that it will still take a long time to fully overcome. Diabetes Mellitus is associated with a poor prognosis for COVID-19, and the COVID-19 pandemic is also known to negatively impact the clinical course of DM. This session will discuss the efforts of healthcare professionals to address various clinical problems related to COVID-19 in Asian patients with diabetes..
Jae Hyun Bae Korea University, Korea	S3-1Glycometabolic control in COVID-19: considerations in the Asian population
Jaehun Jung Gachon University College of Medicine, Korea	S3-2How has covid-19 affected other chronic diseases?: A national-wide population based study
Yukiko Onishi The Institute of Medical Science, Asahi Life Foundation, Japan	S3-3Diabetes management during COVID-19 pandemic in Tokyo - telemedicine or clinic visit?
Ming-Hua Zheng The First Affiliated Hospital of Wenzhou Medical University, China	S3-4Obesity, MAFLD, diabetes and Covid-19

S15 Epidemiology and genetics 2 : Genetics and precision medicine in diabetes: are we there yet? LIVE Channel C	09:00~11:00 / Saturday 9 October Chairman:Kyong Soo Park, Sung-Hoon Kim	Overview
This session will cover both basic genetic research and its clinical translation in diabetes. The first two speakers will review cutting-edge science in the genetics of diabetes and cardio-metabolic traits using large-scale biobanks and uncover genetic risk factors that are specific in Asians. This will be followed by two presentations that focus on the clinical utility of the genetic findings in terms of polygenic risk scores and monogenic diabetes. We hope this session will provide insights on the promises as well as shortcomings of precision medicine in diabetes.
Seung Hoan Choi Broad Institute of MIT & Harvard, USA	S15-1Rare genetic variation underlying cardiometabolic diseases and traits: results from 200,000 individuals in the UK biobank
Xueling Sim National University of Singapore, Singapore	S15-2East Asian specific genetic risk factor of diabetes and metabolic traits
Ken Suzuki Osaka University, Japan	S15-3Progress in genetic research of type 2 diabetes and polygenic risk scores
Soo Heon Kwak Seoul National University Hospital, Korea	S15-4Rare variants in youth-onset type 2 diabetes and monogenic diabetes

S19 Epidemiology and genetics 3 : Prediction model for diabetes and metabolic diseases LIVE Channel C	14:30~16:30 / Saturday 9 October Chairman:Cheol Soo Choi, Jioh Mok	Overview
For effective prevention and management of Diabetes Mellitus (DM), accurate prediction of which person will progress to DM in a population is a very important clinical issue. This session was composed based on the latest research done by major domestic researchers in the related field who are trying to develop an effective predictive model for Korean DM patients and seek clinical application.
Kyoung Hwa Ha Ajou University, Korea	S19-1Development and validation of a conventional risk prediction model for diabetes: a Korean national cohort study
Tae Jung Oh Seoul National University, Korea	S19-2One-hour postprandial hyperglycemia in predicting diabetes
Ji Hye Huh Hallym University, Korea	S19-3Metabolic syndrome severity score for predicting cardiovascular events
Sang Youl Rhee Kyung Hee University, Korea	S19-4Development and validation of a deep learning based diabetes prediction system using a nationwide populationbased cohort

Main symposia